2021, Volume 67, Issue 3  | | EDITORIAL |
| 177-178 |
Information of Clarivate
|
   |
| 181-184 |
EDITORIAL
|
|
| 185-186 |
The Institute of Biomedical Chemistry is a member of the world-class Scientific Center for Digital Biodesign and Personalized Health Care
|
|
| REVIEWS |
| 187-200 |
Radchenko E.V., Tarakanova A.S., Karlov D.S., Lavrov M.I., Palyulin V.A.
Ligands of the AMPA-subtype glutamate receptors: mechanisms of action and novel chemotypes
|
|
| EXPERIMENTAL STUDIES |
| 201-212 |
Kalya M.P., Beisbarth T., Kel A.
Master regulators associated with poor prognosis in glioblastoma multiforme
|
  |
| 213-221 |
Tiis R.P., Osipova L.P., Galieva E.R., Lichman D.V., Voronina E.N., Melikhova A.V., Orlov Y.L., Filipenko M.L.
N-aсetyltransferase (NAT2) gene polymorphism and gene network analysis
|
|
| 222-230 |
Orlov Y.L., Galieva A.G., Orlova N.G., Ivanova E.N., Mozyleva Y.A., Anashkina A.A.
Reconstruction of gene network associated with Parkinson disease for gene targets search
|
|
| 231-243 |
Kurpe S.R., Grishin S.Yu., Glyakina A.V., Slizen M.V., Panfilov A.V., Kochetov A.P., Surin A.K., Kobyakova M.I., Fadeev R.S., Galzitskaya O.V.
Antibacterial effects of peptides synthesized based on the sequence of ribosome protein S1
|
|
| 244-250 |
Bibilashvili R.Sh., Sidorova M.V., Dudkina U.S., Palkeeva M.E., Molokoedov A.S., Kozlovskaya L.I., Egorov A.M., Ishmukhametov A.A., Parfyonova Ye.V.
Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor
|
|
| 251-258 |
Kniga A.E., Polyakov I.V., Nemukhin A.V.
In silico specificity determination of neoantigen-reactive T-lymphocytes
|
|
| 259-267 |
Sulimov A.V., Shikhaliev Kh.S., Pyankov O.V., Shcherbakov D.N., Chirkova V.Yu., Ilin I.S., Kutov D.C., Tashchilova A.S., Krysin M.Yu., Krylskiy D.V., Stolpovskaya N.V., Volosnikova E.A., Belenkaya S.V., Sulimov V.B.
Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease
|
|
| 268-277 |
Vassiliev P.M., Spasov A.A., Kochetkov A.N., Perfilev M.A., Koroleva A.R.
Consensus ensemble neural network multitarget model of RAGE inhibitory activity of chemical compounds
|
|
| 278-288 |
Ionov N.S., Baryshnikova M.A., Bocharov E.V., Pogodin P.V., Lagunin A.A., Filimonov D.A., Karpova R.V., Kosorukov V.S., Stilidi I.S., Matveev V.B., Bocharova O.A., Poroikov V.V.
Possibilities of in silico estimations for the development of pharmaceutical composition phytoladaptogene cytotoxic for bladder cancer cells
|
|
| 289-294 |
Zefirov N.A., Mamaeva A.V., Radchenko E.V., Milaeva E.R., Kuznetsov S.A., Zefirova O.N.
Conjugate of podophyllotoxin with chlorambucil: synthesis, biological testing and molecular modeling
|
|
| 295-299 |
Korotkevich E.I., Rudik A.V., Dmitriev A.V., Lagunin A.A., Filimonov D.A.
Predict of metabolic stability of xenobiotics by the PASS and GUSAR programs
|
|
| 300-305 |
Kulakova A.M., Khrenova M.G., Nemukhin A.V.
Molecular mechanism of chromogenic substrate hydrolysis in the active site of human carboxylesterase-1
|
|
| |